drugset / Trial / NCT00261313
ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a study of dose dense doxorubicin/cyclophosphamide (AC) followed by paclitaxel (Taxol; T) with pegfilgrastim (Neulasta) and darbepoetin alfa support in the adjuvant breast cancer setting.
Timeline
- Start
- 2005-12
- Primary completion
- 2007-06
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Darbepoetin alfa | Protein / enzyme biologic | 300 ug | — |
| Background | Pegfilgrastim | Protein / enzyme biologic | 6 mg | — |